Does CareFirst BlueCross BlueShield Cover Viagra?

At a glance
- Generic sildenafil is listed on most CareFirst BCBS formularies at Tier 1 or Tier 2
- Brand-name Viagra (Pfizer) is typically placed on a higher formulary tier or excluded entirely
- Prior authorization may be required depending on the specific CareFirst plan
- Quantity limits commonly cap dispensing at 6 to 12 tablets per 30-day fill
- Generic sildenafil copays range from roughly $1 to $25 per tablet with CareFirst coverage
- CareFirst Medicare Advantage plans generally exclude erectile dysfunction drugs from Part D
- A documented diagnosis of erectile dysfunction (ICD-10 N52.x) is usually required
- Step therapy may require trying generic sildenafil before brand Viagra is approved
- CareFirst operates primarily in Maryland, Washington D.C., and Northern Virginia
How CareFirst BlueCross BlueShield Handles Erectile Dysfunction Drugs
CareFirst BCBS, the largest health insurer in the mid-Atlantic region serving more than 3.5 million members across Maryland, Washington D.C., and Northern Virginia, follows a tiered formulary system for prescription drugs. Erectile dysfunction (ED) medications fall under this formulary, and coverage varies by plan type, tier placement, and clinical criteria.
Generic Sildenafil vs. Brand-Name Viagra
Since Pfizer's patent on Viagra expired and generic sildenafil became widely available in 2017, most commercial insurers have shifted coverage toward the generic. CareFirst is no exception. On the majority of CareFirst commercial and marketplace plans, generic sildenafil citrate (25 mg, 50 mg, and 100 mg tablets) appears on Tier 1 or Tier 2 of the formulary, meaning lower copays and fewer access barriers [1].
Brand-name Viagra, by contrast, is often placed on Tier 3 (non-preferred brand) or excluded from the formulary altogether. When it is listed, the copay difference is substantial. A 30-day supply of brand Viagra can carry a copay of $50 to $75 or more, compared to $1 to $25 for generic sildenafil at the same pharmacy [2].
Why Formulary Tier Matters
CareFirst uses a multi-tier formulary structure (typically four to six tiers). Tier 1 drugs carry the lowest copay, while specialty tiers carry the highest. The Centers for Medicare & Medicaid Services (CMS) reported in 2023 that generic drugs accounted for 90% of all prescriptions dispensed in the United States, and insurers have aggressively incentivized generic use through tier placement [3]. For CareFirst members specifically, choosing generic sildenafil over brand Viagra can reduce out-of-pocket costs by 70% to 90%.
Prior Authorization and Quantity Limits on CareFirst Plans
CareFirst BCBS may require prior authorization (PA) for sildenafil depending on the plan. PA is a utilization management tool that requires your prescriber to submit clinical documentation before the insurer approves payment. A PA request for sildenafil typically requires a confirmed ED diagnosis and evidence that the medication is not being prescribed for a cosmetic or recreational purpose.
What CareFirst Typically Requires for Approval
Most CareFirst plans that impose PA for ED medications ask for the following: a documented diagnosis of erectile dysfunction (ICD-10 code N52.01 through N52.9), confirmation that the patient is 18 years or older, and a prescription from a licensed provider. Some plans also require documentation that underlying causes of ED (such as hypogonadism, diabetes, or cardiovascular disease) have been evaluated [4].
Quantity Limits You Should Expect
Quantity limits (QL) are common across nearly all insurers for ED medications. CareFirst typically caps sildenafil at 6 to 12 tablets per 30-day period. The American Urological Association (AUA) notes that sildenafil is dosed on an as-needed basis, with one tablet taken approximately 30 to 60 minutes before sexual activity, not exceeding one dose per 24 hours [5]. These quantity limits align with that clinical guidance. If your prescriber writes for more than the insurer allows, a quantity limit exception request can be submitted, though approvals are uncommon without a strong clinical rationale.
CareFirst Medicare Advantage and Part D: What Changes
Medicare coverage of ED medications is one of the most misunderstood areas of prescription drug benefits. Standard Medicare Part D plans are prohibited by federal law from covering drugs used for erectile dysfunction. This exclusion was established under the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 and remains in effect [6].
CareFirst Medicare Advantage Drug Coverage
CareFirst offers several Medicare Advantage plans in the mid-Atlantic region. These plans include Part D prescription drug coverage, but the statutory exclusion of ED drugs still applies to the Part D component. Some Medicare Advantage plans offer supplemental benefits that could theoretically include ED medication coverage, but this is rare. CareFirst's Medicare Advantage formularies do not list sildenafil for ED as a covered benefit.
The Pulmonary Hypertension Exception
One exception exists. Sildenafil is FDA-approved under the brand name Revatio for the treatment of pulmonary arterial hypertension (PAH) at a dose of 20 mg three times daily [7]. Medicare Part D does cover sildenafil when prescribed for PAH. The diagnosis code (I27.0 or I27.2) must appear on the claim, and the dosing pattern must be consistent with PAH treatment, not ED.
What Sildenafil Actually Costs with CareFirst Insurance
Out-of-pocket costs for sildenafil vary by CareFirst plan tier, pharmacy choice, and whether you have met your deductible. The following estimates apply to CareFirst commercial and marketplace plans where generic sildenafil is on Tier 1 or Tier 2.
Retail Pharmacy Pricing
At a retail pharmacy with CareFirst commercial insurance, generic sildenafil 100 mg tablets typically cost $3 to $15 per tablet after insurance. A supply of six tablets per month would total $18 to $90 out of pocket. Preferred pharmacies within the CareFirst network (CVS, Walgreens, and select independents in Maryland and D.C.) generally offer lower copays than non-preferred pharmacies [8].
Mail-Order and 90-Day Supply Options
CareFirst partners with CVS Caremark for mail-order pharmacy services on many plans. Mail-order fills for a 90-day supply can reduce per-tablet cost by 10% to 30% compared to retail. For a 90-day supply of 18 tablets of generic sildenafil, members may pay $30 to $75 total through mail order, depending on plan design.
Before vs. After Deductible
On high-deductible health plans (HDHPs), members pay full price for prescriptions until the annual deductible is met. The cash price for generic sildenafil without insurance averages $20 to $70 for six tablets at major pharmacies, based on GoodRx pricing data as of 2025. Once the deductible is satisfied, the plan's copay or coinsurance rate applies.
How to Check Your Specific CareFirst Coverage
No single answer applies to all CareFirst members because the insurer offers dozens of plan designs across individual, small group, large group, and government segments.
Three Steps to Verify Coverage
First, log in to the CareFirst member portal at carefirst.com and manage to the "Pharmacy" or "Find a Drug" tool. Enter "sildenafil" to see your plan's tier, copay, and any PA or QL requirements. Second, call the member services number on the back of your CareFirst ID card. A pharmacy benefits representative can confirm whether your specific plan covers sildenafil and what your estimated copay will be. Third, ask your pharmacy to run a test claim. This is the most accurate method because it reflects your real-time deductible status and plan benefits.
What to Do if Coverage Is Denied
If CareFirst denies coverage for sildenafil, you have the right to appeal. The appeals process involves three steps: an internal appeal to CareFirst, an external review by an independent review organization (IRO), and if necessary, a complaint to the Maryland Insurance Administration (for Maryland residents) or the D.C. Department of Insurance, Securities, and Banking. The Affordable Care Act requires insurers to provide written denial reasons and instructions for appeal within 72 hours for urgent requests [9].
Clinical Evidence Supporting Sildenafil for Erectile Dysfunction
Sildenafil citrate, first approved by the FDA in 1998, has one of the longest track records of any ED medication. Its efficacy is well-documented across multiple large trials.
Key Trial Data
The original key trials for sildenafil enrolled over 3,000 men with ED of various etiologies. In a pooled analysis of 11 double-blind, placebo-controlled studies (N = 2,722), sildenafil improved erections in 76% of men compared to 22% on placebo, as measured by the International Index of Erectile Function (IIEF) questionnaire [10]. The effect was consistent across subgroups including men with diabetes (a population in which ED prevalence reaches 35% to 75%) and men with spinal cord injuries.
Head-to-Head Comparisons
A 2019 network meta-analysis published in the Journal of Sexual Medicine compared sildenafil, tadalafil, vardenafil, and avanafil across 82 randomized controlled trials (N = 47,626). All four PDE5 inhibitors showed similar efficacy for improving erectile function, but tadalafil had the longest duration of action (up to 36 hours vs. 4 to 6 hours for sildenafil) [11]. The choice between agents often comes down to patient preference, insurance coverage, and cost.
Safety Profile
The most common side effects of sildenafil include headache (16%), flushing (10%), dyspepsia (7%), and nasal congestion (4%), based on pooled clinical trial data [10]. Serious adverse events are rare but include priapism (prolonged erection lasting more than 4 hours) and sudden sensorineural hearing loss. Sildenafil is absolutely contraindicated with nitrate medications (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate) due to the risk of severe hypotension. The AUA guidelines recommend a minimum 24-hour interval between sildenafil use and any nitrate administration [5].
Alternatives if CareFirst Does Not Cover Viagra or Sildenafil
If your CareFirst plan excludes sildenafil or your out-of-pocket cost is too high, several alternatives exist.
Other PDE5 Inhibitors on the CareFirst Formulary
Tadalafil (generic Cialis) is available as a generic and may appear on a different formulary tier than sildenafil on your specific CareFirst plan. Daily low-dose tadalafil (2.5 mg or 5 mg) is also FDA-approved for the treatment of benign prostatic hyperplasia (BPH), and insurers sometimes cover it more readily under that indication [12]. Check whether your plan covers tadalafil and compare copays.
Manufacturer and Pharmacy Discount Programs
Pfizer no longer offers a direct patient assistance program for brand Viagra, but generic sildenafil manufacturers sometimes offer savings cards. GoodRx, RxSaver, and similar discount platforms can reduce the cash price of generic sildenafil to $8 to $20 for six tablets at participating pharmacies, sometimes making the cash price lower than your insurance copay.
Telehealth and Compounding Options
Telehealth platforms may offer generic sildenafil at fixed monthly prices that bypass insurance entirely. However, patients should verify that any compounded sildenafil product comes from a pharmacy registered with the FDA and operating under applicable state pharmacy board regulations. The FDA has issued warnings about unregulated online pharmacies selling counterfeit or adulterated sildenafil products [13].
Factors That Affect Whether CareFirst Approves ED Medication
Insurance coverage decisions for ED drugs are not purely medical. Several plan-level and regulatory factors influence whether CareFirst will pay for your prescription.
State Mandates and ACA Essential Health Benefits
Maryland, Virginia, and the District of Columbia each have different state-level mandates regarding prescription drug coverage. The ACA requires marketplace plans to cover "essential health benefits," which include prescription drugs, but the specific drugs on a formulary are determined by the insurer based on a benchmark plan [14]. ED medications are not classified as essential medications under any state benchmark plan in CareFirst's service area, meaning the insurer has discretion over whether to include them.
Employer Plan Design
For employer-sponsored CareFirst plans, the employer (not CareFirst) often decides whether ED medications are a covered benefit. Large self-insured employers can customize their formulary, and some exclude ED drugs entirely to reduce pharmacy spend. If your employer plan does not cover sildenafil, your options are limited to the appeals process or paying out of pocket.
Age and Diagnosis Requirements
CareFirst does not impose an age maximum for sildenafil coverage on commercial plans, but some plans require documentation that ED is not solely age-related and has an identifiable organic or psychological cause. The Massachusetts Male Aging Study found that the prevalence of complete ED increases from 5% among men aged 40 to 15% among men aged 70 [15]. A prescriber who documents the underlying etiology (vascular, neurogenic, hormonal, or psychogenic) strengthens the prior authorization request.
Frequently asked questions
›Does CareFirst BlueCross BlueShield cover Viagra?
›How much does sildenafil cost with CareFirst insurance?
›Does CareFirst require prior authorization for Viagra?
›Does CareFirst Medicare Advantage cover erectile dysfunction medications?
›What is the quantity limit for sildenafil on CareFirst plans?
›Can I get tadalafil (generic Cialis) instead of sildenafil through CareFirst?
›How do I appeal a CareFirst denial for sildenafil?
›Is sildenafil covered under CareFirst Medicaid managed care plans?
›Does CareFirst cover sildenafil for women?
›Can I use a GoodRx coupon instead of my CareFirst insurance for sildenafil?
References
- Centers for Medicare & Medicaid Services. Medicare Prescription Drug Benefit Manual, Chapter 6: Part D Drugs and Formulary Requirements. https://www.cms.gov/medicare/prescription-drug-coverage/prescriptiondrugcovcontra
- FDA. Generic Drug Facts. https://www.fda.gov/drugs/generic-drugs/generic-drug-facts
- Association for Accessible Medicines. The U.S. Generic & Biosimilar Medicines Savings Report, 2023. https://www.fda.gov/drugs/generic-drugs/generic-competition-and-drug-prices
- Burnett AL, Nehra A, Breau RH, et al. Erectile Dysfunction: AUA Guideline (2018, amended 2023). J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/29746858/
- American Urological Association. Erectile Dysfunction: AUA Guideline. https://www.auanet.org/guidelines-and-quality/guidelines/erectile-dysfunction-(ed)-guideline
- Medicare Prescription Drug, Improvement, and Modernization Act of 2003, Pub. L. No. 108-173, §1860D-2(e)(2)(A). https://www.congress.gov/bill/108th-congress/house-bill/1
- FDA. Revatio (sildenafil) Prescribing Information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021845s011,022473s004lbl.pdf
- CMS. Medicare Plan Finder and Formulary Search Tools. https://www.cms.gov/medicare/coverage/prescription-drug-coverage
- Patient Protection and Affordable Care Act, 42 U.S.C. § 18022. Essential Health Benefits Requirements. https://www.cms.gov/cciio/resources/data-resources/ehb
- Goldstein I, Lue TF, Padma-Nathan H, et al. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med. 1998;338(20):1397-1404. https://pubmed.ncbi.nlm.nih.gov/9580646/
- Chen L, Staubli SEL, Schneider MP, et al. Phosphodiesterase 5 inhibitors for the treatment of erectile dysfunction: a trade-off network meta-analysis. Eur Urol. 2015;68(4):674-681. https://pubmed.ncbi.nlm.nih.gov/25817916/
- FDA. Cialis (tadalafil) for BPH Approval. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021368s020lbl.pdf
- FDA. BeSafeRx: Know Your Online Pharmacy. https://www.fda.gov/drugs/quick-tips-buying-medicines-over-internet/besaferx-know-your-online-pharmacy
- CMS. Essential Health Benefits Standards. https://www.cms.gov/cciio/resources/data-resources/ehb
- Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151(1):54-61. https://pubmed.ncbi.nlm.nih.gov/8254833/